Dashboard
Manage Tickers

CYTKCYTOKINETICS INC

Nasdaq cytokinetics.com


$ 57.37 $ 1.41 (2.52 %)    

Monday, 15-Jul-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 496.90 $ 1.33 (0.27 %)
DIA $ 402.52 $ 2.04 (0.51 %)
SPY $ 561.53 $ 1.54 (0.28 %)
TLT $ 92.88 $ -1.08 (-1.15 %)
GLD $ 223.86 $ 0.72 (0.32 %)
$ 57.39
$ 55.94
$ 0.00 x 0
$ 0.00 x 0
$ 55.62 - $ 57.46
$ 25.98 - $ 110.25
1,074,096
na
5.85B
$ 0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-04-2020 12-31-2019 10-K
19 11-01-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-07-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-05-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 03-06-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-03-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-04-2015 03-31-2015 10-Q
38 03-06-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-overweight-on-cytokinetics-lowers-price-target-to-65
JP Morgan Maintains Overweight on Cytokine...
06/24/2024 11:56:27

JP Morgan analyst Tessa Romero maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and lowers the price target from $77 t...

hc-wainwright--co-reiterates-buy-on-cytokinetics-maintains-90-price-target
HC Wainwright & Co. Reiterates Buy on Cyto...
06/17/2024 14:55:09

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $90 price ta...

cytokinetics-has-dosed-the-first-participants-in-a-phase-1-study-evaluating-the-pharmacokinetics-safety-and-tolerability-of-aficamten-in-healthy-japanese-and-caucasian-participants
Cytokinetics Has Dosed The First Participa...
06/17/2024 11:32:09

peering-into-cytokineticss-recent-short-interest
Peering Into Cytokinetics's Recent Short I...
06/07/2024 16:45:14

cytokinetics-engaged-in-acquisition-talks-with-potential-strategic-partner-for-aficamten-following-positive-phase-3-sequoia-hcm-results-negotiations-did-not-lead-to-acquisition
Cytokinetics Engaged In Acquisition Talks ...
06/05/2024 14:06:21

b-riley-securities-maintains-buy-on-cytokinetics-lowers-price-target-to-92
B. Riley Securities Maintains Buy on Cytok...
06/04/2024 16:47:35

B. Riley Securities analyst Mayank Mamtani maintains Cytokinetics (NASDAQ:CYTK) with a Buy and lowers the price target from ...

jmp-securities-reiterates-market-outperform-on-cytokinetics-maintains-78-price-target
JMP Securities Reiterates Market Outperfor...
05/31/2024 15:29:48

JMP Securities analyst Jason Butler reiterates Cytokinetics (NASDAQ:CYTK) with a Market Outperform and maintains $78 price t...

truist-securities-maintains-buy-on-cytokinetics-lowers-price-target-to-70
Truist Securities Maintains Buy on Cytokin...
05/29/2024 12:53:12

Truist Securities analyst Srikripa Devarakonda maintains Cytokinetics (NASDAQ:CYTK) with a Buy and lowers the price target f...

jmp-securities-maintains-market-outperform-on-cytokinetics-lowers-price-target-to-78
JMP Securities Maintains Market Outperform...
05/28/2024 16:10:21

JMP Securities analyst Jason Butler maintains Cytokinetics (NASDAQ:CYTK) with a Market Outperform and lowers the price targe...

dow-dips-over-550-points-bjs-wholesale-club-earnings-beat-views
Dow Dips Over 550 Points; BJ's Wholesale C...
05/23/2024 18:40:33

heart-disease-focused-cytokinetics-operations-are-on-track-despite-acquisition-uncertainty-analysts-observe
Heart Disease-Focused Cytokinetics Operati...
05/23/2024 18:30:40

Unlock the latest on Royalty Pharma plc & Cytokinetics Inc.'s strategic funding collaboration for aficamten's comme...

8-health-care-stocks-whale-activity-in-todays-session
8 Health Care Stocks Whale Activity In Tod...
05/23/2024 17:35:21

hc-wainwright--co-maintains-buy-on-cytokinetics-lowers-price-target-to-90
HC Wainwright & Co. Maintains Buy on Cytok...
05/23/2024 17:03:16

HC Wainwright & Co. analyst Joseph Pantginis maintains Cytokinetics (NASDAQ:CYTK) with a Buy and lowers the price target...

b-of-a-securities-maintains-neutral-on-cytokinetics-lowers-price-target-to-60
B of A Securities Maintains Neutral on Cyt...
05/23/2024 16:55:39

B of A Securities analyst Jason Zemansky maintains Cytokinetics (NASDAQ:CYTK) with a Neutral and lowers the price target fro...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 16:31:11

gold-falls-sharply-us-composite-pmi-surges-in-may
Gold Falls Sharply; US Composite PMI Surge...
05/23/2024 16:01:36

barclays-maintains-overweight-on-cytokinetics-lowers-price-target-to-95
Barclays Maintains Overweight on Cytokinet...
05/23/2024 15:37:40

Barclays analyst Carter Gould maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and lowers the price target from $100 t...

why-cytokinetics-cytk-shares-are-falling
Why Cytokinetics (CYTK) Shares Are Falling
05/23/2024 14:42:49

Cytokinetics shares are trading lower by 15.8% during Thursday's session. The company announced the pricing of a public off...

raymond-james-maintains-outperform-on-cytokinetics-lowers-price-target-to-70
Raymond James Maintains Outperform on Cyto...
05/23/2024 14:26:03

Raymond James analyst Sean McCutcheon maintains Cytokinetics (NASDAQ:CYTK) with a Outperform and lowers the price target fro...

Core News & Articles
Market-Moving News for May 23rd
05/23/2024 12:40:36

NVDA: 7.77% | NVIDIA shares are trading higher after the company reported better-than-expected Q1 2025 financial results and is...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)